Device Latitude_crm

Latitude Communicator Power Supply

Payments companies reported to CMS as associated with Latitude Communicator Power Supply. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$57Kassociated payments (2023-2025)
1,342clinicians with associated payments
1company reporting

By year

2023 $18K
2024 $19K
2025 $21K

Payments reported as associated with Latitude Communicator Power Supply, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Clinical Cardiac Electrophysiology $14K
Cardiovascular Disease $11K
Family $5,004
Interventional Cardiology $4,202
Nurse Practitioner $3,144
Internal Medicine $3,052

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Latitude Communicator Power Supply

These are the largest totals companies reported as associated with Latitude Communicator Power Supply. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Anish Amin Columbus, OH Clinical Cardiac Electrophysiology $2,375.00
Thomas Geramita Morristown, NJ Surgical $783.83
Rizwan Alimohammad Albany, NY Cardiovascular Disease $695.15
Gina Chavarria Albany, NY Adult Health (Nurse Practitioner) $574.35
Jitender Munjal Tucson, AZ Clinical Cardiac Electrophysiology $445.66
Donald Rhodes Opelika, AL Interventional Cardiology $345.26
Sonja Brune San Antonio, TX Nurse Practitioner $332.22
Dana Sisco Suffern, NY Acute Care (Nurse Practitioner) $301.19
Meghan Emig Charlotte, NC Physician Assistant $290.00
Daniel Cobb Savannah, GA Clinical Cardiac Electrophysiology $278.89

Prescribed Latitude Communicator Power Supply?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.